Infinity Pharmaceuticals Inc (NASDAQ:INFI) Announces Q2 Results: Stock Jumps a Bit

August 17, 2021

Clinical stage biotech firm Infinity Pharmaceuticals Inc (NASDAQ:INFI) has been on the sights of investors over the course of the past week and during that period, the company’s stock has managed to clock gains of as much as 7%. However, at the same time, investors need to also remember that there has been no news about the company in the past week and the rally could also be speculative in…

Read More >>

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Stock Soars 30% This Week: What’s Going On?

August 6, 2021

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) is up 32% in a week after announcing a grant of inducement restricted stock and stock option award to the recently hired Chief Scientific Officer, Stephane Peluso, as per the employment letter offer. The company’s Board of Directors Compensation Committee approved the grants, which were made as incentives for Peluso’s acceptance of employment as per the Nasdaq Listing Rule 5635(C)(4). The award comprises a stock option…

Read More >>